Imaging & Diagnostics

The intricate process of diagnosing illness in modern medicine often begins with a simple image, yet a growing crisis within the UK's National Health Service (NHS) reveals that the interpretation of these critical scans is fraught with peril. A sharp increase in clinical negligence claims related

A critical disruption in Saskatchewan's diagnostic imaging services has left numerous cancer patients in a state of prolonged uncertainty after the province's only positron emission tomography scanner was forced into a sudden shutdown. The vital piece of equipment, located at Saskatoon's Royal

In vitro diagnostics (IVDs) wield a disproportionate influence on modern medicine, informing nearly two-thirds of all clinical decisions while accounting for a mere two percent of total healthcare spending in the United States. This unique position places immense pressure on IVD manufacturers to

Receiving a call back after a routine screening mammogram can be an incredibly stressful experience, initiating a period of uncertainty for thousands of women each year while clinicians face the critical challenge of distinguishing benign findings from genuine malignancies. The goal is always to

A routine visit for a new pair of glasses or a preventative screening can take an unexpected turn when the intake form or a clinician begins asking about ethnicity, marital status, or housing stability. For many, these questions feel deeply personal and irrelevant to the immediate medical issue,

The advent of targeted radiopharmaceutical therapies like (177Lu)Lu-PSMA-617 has offered a significant new weapon in the fight against metastatic castration-resistant prostate cancer (mCRPC), but predicting which patients will benefit most versus those who will suffer severe side effects remains a